IL17A and pulmonary fibrosis: Another study by Smith et al reported that the blockade of IL‐17A activity decreases the incidence of atherosclerosis in ApoE2/2 mice,26 and Wilson et al also demonstrated that BLM‐mediated pulmonary fibrosis is dependent on IL‐17A.27